Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (LSE ... and includes fundamentals, analyst reports, ownership data and fund sentiment, options ...

Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...

Shares of Quest Diagnostics Inc. DGX slid 3.78% to $164.18 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 5.97% to 5,074.08 ...

Med Tech & Diagnostics Analysts ... and leadless devices (relevant companies ABT ATRC BSX HAE JNJ MDT) on an Analyst/Industry conference call to be held on April 10 at 11:45 am.

I had a very NASTY MANNERED technician. I believe she cared more about her makeup that morning than her patient's feelings. She shhhhhed me in mid-sentence and I had to remind her to say, "please ...

In March, we welcomed 30 new analysts to Seeking Alpha, and in this article we are showcasing their stock picks and ...

Since the launch of the Quest platform in 2019, overall revenue earned by developers showed promising growth through the Quest 2 era. But in the last two years, revenue on the store growth has slowed.